Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The outcomes of the 2021 Research Excellence Framework (REF) are now available. The Radcliffe Department of Medicine contributed to Unit of Assessment (UOA) 1, Clinical Medicine, with other departments from the Medical Sciences Division.

Professor Keith Channon, Head of the Department, said “In UOA 1, Oxford’s return was the largest overall and had the largest volume of 4* research, which is the highest score for research quality that is world-leading in terms of originality, significance, and rigour. I am also delighted that the number of researchers included in our UOA1 REF return was double that in REF 2014, and that we scored the highest possible score (100% 4*) for our Environment submission, reflecting our outstanding people, the way we organise and deliver our research and graduate teaching, and the facilities in which we work.”

“Very many thanks, and congratulations, to all RDM researchers whose excellent work contributed to the REF submission – and to the staff, students and the many support teams across RDM who together make for such a productive research culture and environment.”

You can find out more about the University of Oxford REF results on Medical Sciences Division website.

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

Anjali Kusumbe receives the RMS Life Sciences Medal

The Royal Microscopical Society awards celebrate the best in microscopy, recognising those making a special contribution to microscopy, cytometry and imaging.

Enterprise Associate Interview with Dr Shilpa Nagarajan

Dr Shilpa Nagarajan is one of the MPLS Enterprise and Innovation Fellows for 2022-23.

The Gene Therapists Headline at Glastonbury 2022

Rosie Munday writes about her experience taking science to the masses at the Glastonbury Festival.

Intensive blood glucose control for people with type 2 diabetes when they are first diagnosed reduces diabetic complications and prolongs life

The study, which tracked volunteers for up to 44 years, showed that the benefits of early intensive blood glucose control can persist for decades.

Wellcome Trust funding success for Jim Hughes and James Davies

£3.6 million in funding awarded by the Wellcome Trust to combine cutting-edge 3D genome technologies with machine learning approaches to decipher the role of the non-coding genome in disease.